Individualized Care Perceptions of Patients Receiving Outpatient Chemotherapy: A Qualitative Study

April 20, 2026 updated by: Seyda Can, University of Yalova

The purpose of this observational study is to learn how people receiving chemotherapy in a clinic without staying overnight (outpatient) feel about the care they receive. The study focuses on individualized care, which means nursing care that is tailored specifically to each person's unique needs, values, and lifestyle.

Background:

Cancer treatment often involves chemotherapy (medicine used to kill cancer cells). While these treatments help fight the disease, they can also cause side effects like nausea or tiredness, which affect daily life. Nurses play a key role in helping people manage these effects. This research aims to understand how "individualized care" helps participants feel valued and supported during their treatment journey.

The study aims to answer these key questions:

How do participants describe their experiences with nursing care?

What are the specific needs and expectations of these individuals for care that feels personal to them?

How does personalized care affect their ability to manage symptoms and follow their treatment plan?

Scope and Setting:

This study will take place at the Yalova Training and Research Hospital within the Outpatient Chemotherapy Unit. The research will be conducted between May 1, 2026, and April 1, 2027.

Method and Participants:

The researchers plan to interview 10 to 20 participants who are over 18 years old and receiving treatment at the clinic. The final number of participants will be decided when the researchers find that no new information or themes are being discovered in the interviews (a stage called "data saturation").

Participants will:

Take part in a private, one-on-one interview with a researcher.

Answer open-ended questions about their thoughts and feelings regarding their nursing care.

Allow the interview to be voice-recorded to ensure all information is captured accurately.

Spend approximately 30 to 45 minutes sharing their personal experiences.

Privacy and Ethics:

Participant privacy is a top priority. All personal information and voice recordings will be kept strictly confidential. In the final report, fake names (aliases) will be used so that no one can be identified. Participants can choose to leave the study at any time. The study follows international ethical rules to protect the rights of every participant.

Study Overview

Status

Not yet recruiting

Study Type

Observational

Enrollment (Estimated)

10

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

    • Yalova
      • Yalova, Yalova, Turkey (Türkiye), 77200
        • University of Yalova
        • Contact:
        • Contact:
        • Principal Investigator:
          • Seyda CAN, Assoc. Prof.
        • Sub-Investigator:
          • Yasemin KARA OKMEN, BSc

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

Patients receiving ongoing treatment at the Outpatient Chemotherapy Unit of Yalova Training and Research Hospital

Description

Inclusion Criteria:

  • Continuing treatment at the Outpatient Chemotherapy Unit of the relevant hospital.
  • Voluntarily agreeing to participate in the study.
  • Being over 18 years of age.
  • Being proficient in Turkish.
  • Exclusion Criteria:
  • Not receiving ongoing treatment at the Outpatient Chemotherapy Unit of the relevant hospital.
  • Declining to participate in the study voluntarily.
  • Unwillingness to answer questions or lack of cooperation during the interview.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Number of participants expressing specific themes regarding perceptions of individualized nursing care.
Time Frame: Through study completion (approximately 12 months).
This outcome measures the frequency and depth of perceptions of individualized nursing care as shared by participants during semi-structured interviews. Data will be analyzed using descriptive and thematic analysis. The results will be reported as the identified themes and the number of participants who expressed each specific theme or perception.
Through study completion (approximately 12 months).

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Number of participants identifying specific categories of individualized nursing care needs and expectations.
Time Frame: Through study completion (approximately 12 months).
Through semi-structured interviews, participants will describe their specific nursing care needs and expectations. Data will be analyzed to identify common categories of needs. Results will be reported as a list of identified care need categories and the number of participants who expressed each specific need or expectation.
Through study completion (approximately 12 months).

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

  • Yildirim, A., & Simsek, H. (2016). Qualitative Research Methods in the Social Sciences (Sosyal Bilimlerde Nitel Arastirma Yontemleri). Seckin Publishing.
  • Palese, A., Tomietto, M., Suhonen, R., et al. (2011). Surgical patient satisfaction as an outcome of nurses' caring behaviours: A descriptive and correlational study in six European countries. Journal of Nursing Scholarship, 43(4), 341-350.
  • Pekmezci, H., Köse, B. G., & Akbal, Y. (2024). Nursing care from the perspective of cancer patients. Journal of Nursology, 27(2), 146-152.
  • Acaroğlu, R., Suhonen, R., Şendir, M., & Kaya, H. (2010). Reliability and validity of Turkish version of the individualised care scale. Journal of Clinical Nursing, 20(1-2), 136-145.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

May 1, 2026

Primary Completion (Estimated)

April 1, 2027

Study Completion (Estimated)

April 1, 2027

Study Registration Dates

First Submitted

April 12, 2026

First Submitted That Met QC Criteria

April 12, 2026

First Posted (Actual)

April 17, 2026

Study Record Updates

Last Update Posted (Actual)

April 23, 2026

Last Update Submitted That Met QC Criteria

April 20, 2026

Last Verified

April 1, 2026

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

Individual participant data will not be shared to protect the privacy and confidentiality of the participants. Due to the nature of qualitative research, interview transcripts contain sensitive personal experiences that could potentially lead to the identification of participants, even if direct identifiers are removed. Therefore, only aggregated themes and findings will be presented in the final report.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Chemotherapy

Subscribe